Roxana Ghiulai
Overview
Explore the profile of Roxana Ghiulai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mioc M, Mioc A, Racoviceanu R, Ghiulai R, Prodea A, Milan A, et al.
Molecules
. 2023 Jan;
28(1).
PMID: 36615613
One of several promising strategies for increasing the bioavailability and therapeutic potential of high-lipophilic biologically active compounds is gold nanoparticle formulation. The current study describes the synthesis and biological antimelanoma...
2.
Nistor G, Mioc M, Mioc A, Balan-Porcarasu M, Racoviceanu R, Prodea A, et al.
Molecules
. 2022 Nov;
27(22).
PMID: 36431906
Cancer, in all its types and manifestations, remains one of the most frequent causes of death worldwide; an important number of anticancer drugs have been developed from plants, fungi and...
3.
Ghiulai R, Mioc M, Racoviceanu R, Prodea A, Milan A, Coricovac D, et al.
Molecules
. 2022 Nov;
27(21).
PMID: 36364186
Betulinic acid (BA) has been extensively studied in recent years mainly for its antiproliferative and antitumor effect in various types of cancers. Limited data are available regarding the pharmacokinetic profile...
4.
Ghiulai R, Mioc A, Racoviceanu R, Mioc M, Milan A, Prodea A, et al.
Pharmaceuticals (Basel)
. 2022 Nov;
15(11).
PMID: 36355533
Implementing metallic nanoparticles as research instruments for the transport of therapeutically active compounds remains a fundamentally vital work direction that can still potentially generate novelties in the field of drug...
5.
Nistor G, Trandafirescu C, Prodea A, Milan A, Cristea A, Ghiulai R, et al.
Molecules
. 2022 Oct;
27(19).
PMID: 36235089
Medicinal plants have been used by humans since ancient times for the treatment of various diseases and currently represent the main source of a variety of phytocompounds, such as triterpenes....
6.
Mioc M, Mioc A, Prodea A, Milan A, Balan-Porcarasu M, Racoviceanu R, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077389
Pentacyclic triterpenes, such as betulinic, ursolic, and oleanolic acids are efficient and selective anticancer agents whose underlying mechanisms of action have been widely investigated. The introduction of N-bearing heterocycles (e.g.,...
7.
Mioc M, Prodea A, Racoviceanu R, Mioc A, Ghiulai R, Milan A, et al.
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012159
Triterpenic acids are a widespread class of phytocompounds which have been found to possess valuable therapeutic properties such as anticancer, anti-inflammatory, hepatoprotective, cardioprotective, antidiabetic, neuroprotective, lipolytic, antiviral, and antiparasitic effects....
8.
Mioc M, Milan A, Malita D, Mioc A, Prodea A, Racoviceanu R, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887090
Triterpenic acids are phytocompounds with a widespread range of biological activities that have been the subject of numerous in vitro and in vivo studies. However, their underlying mechanisms of action...
9.
Milan A, Mioc A, Prodea A, Mioc M, Buzatu R, Ghiulai R, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163063
The last decade has witnessed a sustained increase in the research development of modern-day chemo-therapeutics, especially for those used for high mortality rate pathologies. However, the therapeutic landscape is continuously...
10.
Prodea A, Mioc A, Banciu C, Trandafirescu C, Milan A, Racoviceanu R, et al.
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35054925
Triterpenic compounds stand as a widely investigated class of natural compounds due to their remarkable therapeutic potential. However, their use is currently being hampered by their low solubility and, subsequently,...